Lipodystrophies Completed Phase 2 Trials for Volanesorsen (DB15067)

Also known as: Lipodystrophy / Lipodystrophy NOS / Lipodystrophy acquired

IndicationStatusPhase
DBCOND0026618 (Lipodystrophies)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02639286Efficacy, Safety and Tolerability of ISIS 304801 in People With Partial Lipodystrophy With an Open-Label ExtensionTreatment